Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Regional Fat Depots and Insulin Resistance
Heterogeneity of Fat Depots
Status: Enrolling
Updated:  4/15/2011
Stanford University
mi
from
Stanford, CA
Regional Fat Depots and Insulin Resistance
Heterogeneity of Fat Depots
Status: Enrolling
Updated: 4/15/2011
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 Diabetes
The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  4/15/2011
University of Virginia
mi
from
Charlottesville, VA
The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 Diabetes
The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 4/15/2011
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
TREAT (Telemedicine for Reach, Education, Access, and Treatment)
TREAT (Telemedicine for Reach, Education, Access, and Treatment)
Status: Enrolling
Updated:  4/19/2011
UPMC Northwest
mi
from
Seneca, PA
TREAT (Telemedicine for Reach, Education, Access, and Treatment)
TREAT (Telemedicine for Reach, Education, Access, and Treatment)
Status: Enrolling
Updated: 4/19/2011
UPMC Northwest
mi
from
Seneca, PA
Click here to add this to my saved trials
Carbohydrate Consumption as a Factor in Aspart Dosing
Carbohydrate Consumption as a Factor in Aspart Dosing Compared to the Regularly Used Standard of Care Basis of Dosing Aspart in the Inpatient Setting (CARB)
Status: Enrolling
Updated:  4/21/2011
Rush University Medical Center
mi
from
Chicago, IL
Carbohydrate Consumption as a Factor in Aspart Dosing
Carbohydrate Consumption as a Factor in Aspart Dosing Compared to the Regularly Used Standard of Care Basis of Dosing Aspart in the Inpatient Setting (CARB)
Status: Enrolling
Updated: 4/21/2011
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Relationship Between Changes in Gut Hormones After Gastric Bypass and Gastric Banding and Improvements in Diabetes
Role of Endogenous Glucagon-like Peptide-1 (GLP-1) in Improved Glucose Tolerance After Two Different Types of Bariatric Surgery
Status: Enrolling
Updated:  4/26/2011
Center for Weight and Eating Disorders, University of Pennsylvania
mi
from
Philadelphia, PA
Relationship Between Changes in Gut Hormones After Gastric Bypass and Gastric Banding and Improvements in Diabetes
Role of Endogenous Glucagon-like Peptide-1 (GLP-1) in Improved Glucose Tolerance After Two Different Types of Bariatric Surgery
Status: Enrolling
Updated: 4/26/2011
Center for Weight and Eating Disorders, University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Public Private Partnership Addressing Literacy-Numeracy to Improve Diabetes Care
The Public Private Partnership Addressing Literacy-Numeracy to Improve Diabetes Care
Status: Enrolling
Updated:  4/28/2011
Vanderbilt University
mi
from
Nashville, TN
The Public Private Partnership Addressing Literacy-Numeracy to Improve Diabetes Care
The Public Private Partnership Addressing Literacy-Numeracy to Improve Diabetes Care
Status: Enrolling
Updated: 4/28/2011
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Effect of Abdominal Obesity on Heart Metabolism and Function
Altered Myocardial Fatty Acid Metabolism In Obesity
Status: Enrolling
Updated:  5/11/2011
Washington University Medical School
mi
from
St. Louis, MO
Effect of Abdominal Obesity on Heart Metabolism and Function
Altered Myocardial Fatty Acid Metabolism In Obesity
Status: Enrolling
Updated: 5/11/2011
Washington University Medical School
mi
from
St. Louis, MO
Click here to add this to my saved trials
Effect of Vitamin D Supplementation on Hemoglobin A1c
Does Vitamin D Supplement Alter Serum Level of Glycosylated Hemoglobin in Adult Patients Between 34-74 Years With Type 2 Diabetes Mellitus and Vitamin D Deficiency?
Status: Enrolling
Updated:  5/13/2011
Genesys East Flint Campus Clinic
mi
from
Flint, MI
Effect of Vitamin D Supplementation on Hemoglobin A1c
Does Vitamin D Supplement Alter Serum Level of Glycosylated Hemoglobin in Adult Patients Between 34-74 Years With Type 2 Diabetes Mellitus and Vitamin D Deficiency?
Status: Enrolling
Updated: 5/13/2011
Genesys East Flint Campus Clinic
mi
from
Flint, MI
Click here to add this to my saved trials
Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus
Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus Using Regadenoson Stress Cardiac Magnetic Resonance Imaging
Status: Enrolling
Updated:  5/26/2011
University of Virginia
mi
from
Charlottesville, VA
Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus
Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus Using Regadenoson Stress Cardiac Magnetic Resonance Imaging
Status: Enrolling
Updated: 5/26/2011
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Andrew J. Lewin Medical Corporation DBA National Research Institute
mi
from
Los Angeles, CA
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Andrew J. Lewin Medical Corporation DBA National Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Center for Clinical Trials, LLC.
mi
from
Paramount, CA
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Center for Clinical Trials, LLC.
mi
from
Paramount, CA
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Orange County Research Center
mi
from
Tustin, CA
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Orange County Research Center
mi
from
Tustin, CA
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Creekside Endocrine Associates PC
mi
from
Denver, CO
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Creekside Endocrine Associates PC
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Clinical Research of South Florida
mi
from
Miami, FL
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Clinical Research of South Florida
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Metabolic Research Institute, Inc.
mi
from
West Palm Beach, FL
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Metabolic Research Institute, Inc.
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Atlanta Pharmaceutical Research
mi
from
Decatur, GA
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Atlanta Pharmaceutical Research
mi
from
Decatur, GA
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
ICCT Research International, Inc.
mi
from
Chicago, IL
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
ICCT Research International, Inc.
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Medstar Health Research Institute
mi
from
Hyattsville, MD
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Medstar Health Research Institute
mi
from
Hyattsville, MD
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Nevada Alliance Against Diabetes
mi
from
Las Vegas, NV
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Nevada Alliance Against Diabetes
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
New Hanover Medical Research
mi
from
Wilmington, NC
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
New Hanover Medical Research
mi
from
Wilmington, NC
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Piedmont Medical Research, LLC.
mi
from
Winston-Salem, NC
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Piedmont Medical Research, LLC.
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Upstate Pharmaceutical Research
mi
from
Greenville, SC
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Upstate Pharmaceutical Research
mi
from
Greenville, SC
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Mountain View Clinical Research
mi
from
Greer, SC
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Mountain View Clinical Research
mi
from
Greer, SC
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Southeastern Research Associates, Inc.
mi
from
Taylors, SC
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Southeastern Research Associates, Inc.
mi
from
Taylors, SC
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Athens Medical Group
mi
from
Athens, TN
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Athens Medical Group
mi
from
Athens, TN
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Juno Research
mi
from
Houston, TX
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Juno Research
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated:  6/6/2011
Cetero Research - San Antonio
mi
from
San Antonio, TX
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Status: Enrolling
Updated: 6/6/2011
Cetero Research - San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers
A Prospective, Randomized Comparative Parallel Study of Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated:  6/6/2011
Advanced Foot Care and Clinincal Research Center
mi
from
Fresno, CA
Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers
A Prospective, Randomized Comparative Parallel Study of Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 6/6/2011
Advanced Foot Care and Clinincal Research Center
mi
from
Fresno, CA
Click here to add this to my saved trials
Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers
A Prospective, Randomized Comparative Parallel Study of Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated:  6/6/2011
Professional Education and Research Institute
mi
from
Roanoke, VA
Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers
A Prospective, Randomized Comparative Parallel Study of Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 6/6/2011
Professional Education and Research Institute
mi
from
Roanoke, VA
Click here to add this to my saved trials
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Status: Enrolling
Updated:  6/7/2011
Clinical Research Facility
mi
from
Denver, CO
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Status: Enrolling
Updated: 6/7/2011
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Status: Enrolling
Updated:  6/7/2011
Clinical Research Facility
mi
from
Grand Island, NE
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Status: Enrolling
Updated: 6/7/2011
Clinical Research Facility
mi
from
Grand Island, NE
Click here to add this to my saved trials
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Status: Enrolling
Updated:  6/7/2011
Clinical Research Facility
mi
from
Henderson, NV
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Status: Enrolling
Updated: 6/7/2011
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
Status: Enrolling
Updated:  6/7/2011
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
Status: Enrolling
Updated: 6/7/2011
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Diet and Activity Promotion Among Older Working Adults
Diet and Activity Promotion Among Older Working Adults
Status: Enrolling
Updated:  6/14/2011
Berkeley Analytics, Inc.
mi
from
Berkeley, CA
Diet and Activity Promotion Among Older Working Adults
Diet and Activity Promotion Among Older Working Adults
Status: Enrolling
Updated: 6/14/2011
Berkeley Analytics, Inc.
mi
from
Berkeley, CA
Click here to add this to my saved trials
Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes
Multicenter Trial to Evaluate the Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetics Who Despite Tight Control and Proper Diet Still Suffer From Metabolic Problems
Status: Enrolling
Updated:  6/21/2011
Global Infusion and Aspiration Systems, LLC
mi
from
Batesville, MS
Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes
Multicenter Trial to Evaluate the Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetics Who Despite Tight Control and Proper Diet Still Suffer From Metabolic Problems
Status: Enrolling
Updated: 6/21/2011
Global Infusion and Aspiration Systems, LLC
mi
from
Batesville, MS
Click here to add this to my saved trials
Supporting Treatment Adherence Needs in Diabetes
Supporting Treatment Adherence Needs in Diabetes: The STAND Study
Status: Enrolling
Updated:  6/21/2011
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Supporting Treatment Adherence Needs in Diabetes
Supporting Treatment Adherence Needs in Diabetes: The STAND Study
Status: Enrolling
Updated: 6/21/2011
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Impaired Wound Healing in Diabetic Foot Ulceration
Impaired Wound Healing in Diabetic Foot Ulceration
Status: Enrolling
Updated:  6/23/2011
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Impaired Wound Healing in Diabetic Foot Ulceration
Impaired Wound Healing in Diabetic Foot Ulceration
Status: Enrolling
Updated: 6/23/2011
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Use of a Computer-Assisted Decision Support (CADS) System in Management of Patients With Type 2 Diabetes
The Use of a Computer-Assisted Decision Support (CADS) System to Improve Outcomes in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  6/24/2011
Walter Reed Army Medical Center
mi
from
Washington,
Use of a Computer-Assisted Decision Support (CADS) System in Management of Patients With Type 2 Diabetes
The Use of a Computer-Assisted Decision Support (CADS) System to Improve Outcomes in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 6/24/2011
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
PAR Regulation of Platelet Function in Diabetic Patients
PAR Regulation of Platelet Function in Diabetic Patients
Status: Enrolling
Updated:  6/29/2011
Vanderbilt University Medical Center
mi
from
Nashville, TN
PAR Regulation of Platelet Function in Diabetic Patients
PAR Regulation of Platelet Function in Diabetic Patients
Status: Enrolling
Updated: 6/29/2011
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Rilonacept in Diabetes Mellitus Type 1: Safety Study
A Phase I, Open-label, Safety Study of Anti-inflammatory Therapy With Rilonacept in Adolescents and Adults With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/29/2011
Children's Medical Center
mi
from
Dallas, TX
Rilonacept in Diabetes Mellitus Type 1: Safety Study
A Phase I, Open-label, Safety Study of Anti-inflammatory Therapy With Rilonacept in Adolescents and Adults With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/29/2011
Children's Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Progression of Diabetic Retinopathy Post Bariatric Surgery (BS)
The Effect of Bariatric Surgery on the Progression of Diabetic Retinopathy
Status: Enrolling
Updated:  7/12/2011
NYU SOM
mi
from
New York, NY
Progression of Diabetic Retinopathy Post Bariatric Surgery (BS)
The Effect of Bariatric Surgery on the Progression of Diabetic Retinopathy
Status: Enrolling
Updated: 7/12/2011
NYU SOM
mi
from
New York, NY
Click here to add this to my saved trials
Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus
Phase II, Open-Label Study to Assess the Cardiovascular Side Effects and Efficacy for Reducing Blood Glucose Level in Type II Diabetes Mellitus Patients Being Treated With RAS 130 With or Without Diet and Exercise
Status: Enrolling
Updated:  7/19/2011
MedCenter
mi
from
East Brunswick, NJ
Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus
Phase II, Open-Label Study to Assess the Cardiovascular Side Effects and Efficacy for Reducing Blood Glucose Level in Type II Diabetes Mellitus Patients Being Treated With RAS 130 With or Without Diet and Exercise
Status: Enrolling
Updated: 7/19/2011
MedCenter
mi
from
East Brunswick, NJ
Click here to add this to my saved trials
Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus
Phase II, Open-Label Study to Assess the Cardiovascular Side Effects and Efficacy for Reducing Blood Glucose Level in Type II Diabetes Mellitus Patients Being Treated With RAS 130 With or Without Diet and Exercise
Status: Enrolling
Updated:  7/19/2011
Robertwood Johnson Hospital
mi
from
New Brunswick, NJ
Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus
Phase II, Open-Label Study to Assess the Cardiovascular Side Effects and Efficacy for Reducing Blood Glucose Level in Type II Diabetes Mellitus Patients Being Treated With RAS 130 With or Without Diet and Exercise
Status: Enrolling
Updated: 7/19/2011
Robertwood Johnson Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus
Phase II, Open-Label Study to Assess the Cardiovascular Side Effects and Efficacy for Reducing Blood Glucose Level in Type II Diabetes Mellitus Patients Being Treated With RAS 130 With or Without Diet and Exercise
Status: Enrolling
Updated:  7/19/2011
Raritan Bay Medical Center
mi
from
Perth Amboy, NJ
Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus
Phase II, Open-Label Study to Assess the Cardiovascular Side Effects and Efficacy for Reducing Blood Glucose Level in Type II Diabetes Mellitus Patients Being Treated With RAS 130 With or Without Diet and Exercise
Status: Enrolling
Updated: 7/19/2011
Raritan Bay Medical Center
mi
from
Perth Amboy, NJ
Click here to add this to my saved trials
Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease
Self-management of Type 2 Diabetes and Chronic Kidney Disease
Status: Enrolling
Updated:  7/19/2011
University of Colorado Hospital
mi
from
Denver, CO
Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease
Self-management of Type 2 Diabetes and Chronic Kidney Disease
Status: Enrolling
Updated: 7/19/2011
University of Colorado Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease
Self-management of Type 2 Diabetes and Chronic Kidney Disease
Status: Enrolling
Updated:  7/19/2011
VA Eastern Colorado Hospital
mi
from
Denver, CO
Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease
Self-management of Type 2 Diabetes and Chronic Kidney Disease
Status: Enrolling
Updated: 7/19/2011
VA Eastern Colorado Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Enhanced Spanish Drug Label Study to Promote Patient Understanding and Use
Enhanced Spanish Drug Label Design to Promote Patient Understanding and Use
Status: Enrolling
Updated:  7/19/2011
Northwestern University
mi
from
Chicago, IL
Enhanced Spanish Drug Label Study to Promote Patient Understanding and Use
Enhanced Spanish Drug Label Design to Promote Patient Understanding and Use
Status: Enrolling
Updated: 7/19/2011
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Diabetes Support Project: Couples Intervention
Improving Diabetes Outcome: The Diabetes Support Project
Status: Enrolling
Updated:  7/20/2011
SUNY Upstate Medical University, Dept. of Psychiatry
mi
from
Syracuse, NY
Diabetes Support Project: Couples Intervention
Improving Diabetes Outcome: The Diabetes Support Project
Status: Enrolling
Updated: 7/20/2011
SUNY Upstate Medical University, Dept. of Psychiatry
mi
from
Syracuse, NY
Click here to add this to my saved trials
Diabetes Support Project: Couples Intervention
Improving Diabetes Outcome: The Diabetes Support Project
Status: Enrolling
Updated:  7/20/2011
University of California - San Francisco
mi
from
San Francisco, CA
Diabetes Support Project: Couples Intervention
Improving Diabetes Outcome: The Diabetes Support Project
Status: Enrolling
Updated: 7/20/2011
University of California - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials